Jamil Khurram bought GALT
May 26, 2026 · Form 4 insider transaction
Jamil Khurram bought 568 shares of Galectin Therapeutics Inc. at $1.23 per share, a transaction worth $698.64. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
568
Price
$1.23
Total value
$698.64
InsiderJamil Khurram
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 26, 2026
Filing dateMay 28, 2026
Shares owned after568
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 2, 2026, as disclosed in the Issuers Quarterly Report on Form 10-Q, filed with the SEC on May 15, 2026